The Front Room — a clinical regulatory commons
RSS
COMPLIANCE PROGRAM 2025 revision

Bioresearch Monitoring Program — Institutional Review Boards

CP 7348.809 U.S. Food & Drug Administration
ABSTRACT — EDITORS' SUMMARY

IRB-side BIMO. What FDA inspects at IRBs — membership, review procedures, recordkeeping. Sponsors need this to manage their IRB oversight obligation.

EMBEDDED PDF
Page of —
DownloadView on FDA ↗
Loading PDF…
METADATA
TypeCOMPLIANCE PROGRAM
Year2025
Version2025 revision
StatusCurrent
FormatPDF
Pages—
Size293 KB
Last reviewedAPR 2025
SOURCE
PDF · CANONICAL LINK https://www.fda.gov/media/75909/download ↗
RELATED · SAME AUTHORITY
FDA 2025
Processes and Practices Applicable to Bioresearch Monitoring Inspections
GUIDANCE 2025
FDA 2025
E6(R3) Good Clinical Practice — Final Guidance for Industry
GUIDANCE 2025
FDA CP 7348.811
Bioresearch Monitoring Program — Clinical Investigators and Sponsor-Investigators
COMPLIANCE PROGRAM 2025
FDA 2024
Decentralized Clinical Trials for Drugs, Biological Products, and Devices
GUIDANCE 2024
FDA 2024
Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations
GUIDANCE 2024